Document is current
Any future updates will be listed below
-
Authors
Lan, Xin
Mi, Tian
Alli, Shanta
Guy, Cliff
Djekidel, Mohamed Nadhir
Liu, Xueyan
Boi, Shannon
Chowdhury, Partha
He, Minghong
Zehn, Dietmar https://orcid.org/0000-0003-1393-8527
Feng, Yongqiang https://orcid.org/0000-0002-2320-5063
Youngblood, Ben https://orcid.org/0000-0002-1261-9957
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI114442)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA237311)
- License Information
-
More Information
Article History
Received: 30 April 2023
Accepted: 16 April 2024
First Online: 30 May 2024
Competing interests
: B.Y. declares patents related to epigenetic biomarkers and methods for enhancing T cell function (US11020430B2). The other authors declare no competing interests.
